DigestRedComo funciona
Red
/
Empresas
Bi
No verificado

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

28 Comunicados de prensa

Ver todos los comunicados de prensa
01/04/2026
Mercado laboral
Industria
Ciencia
Fitness
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
01/04/2026
Mercado laboral
Industria
Salud
Técnica
Biotecnología
Fitness
Farmacéutica
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
30/03/2026
Mercado laboral
Industria
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
30/03/2026
Mercado laboral
Industria
Salud
Biotecnología
Ciencia
Farmacéutica
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
27/03/2026
Industria
Oncología
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
27/03/2026
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Medicina - Varios
Mercado laboral
Industria
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
23/03/2026
Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
23/03/2026
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Medicina - Varios
Sanidad
Mercado laboral
Industria
Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
28/02/2026
Industria
Oncología
Salud
Biotecnología
Medicina - Varios
Farmacéutica
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0
09/01/2026
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)
Fuente
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0